Lv3
240 积分 2025-08-07 加入
Nutritional, functional, and psychological considerations for incretin-based therapies in adults-an EASO, EFAD, and ECPO Consensus Statement
1个月前
已关闭
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once-weekly basal insulin, in healthy participants: A randomized trial. Diabetes Obes Metab
2个月前
已完结
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4 , a novel once‐weekly basal insulin, in healthy participants: A randomized trial
8个月前
已关闭
Switching to once‑weekly insulin icodec versus once‑daily insulin degludec in individuals with basal insulin‑treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat‑to‑target trial
8个月前
已关闭
Once‑weekly insulin Icodec with dosing guide App versus once‑daily basal insulin analogues in insulin‑naive type 2 diabetes(ONWARDS 5): a randomized trial
8个月前
已完结
Once‑weekly insulin icodec vs once‑daily insulin degludec in adults with insulin‑naive type 2 diabetes: the ONWARDS 3 randomized clinical trial
8个月前
已完结
Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes Lovshin, Julie A. Canadian Journal of Diabetes, Volume 41, Issue 5, 524 - 535
1年前
已完结
<p>Patient preferences for glucagon-like peptide-1 receptor&ndash;agonist treatment attributes</p>
1年前
已完结
皖公网安备34019202002308
